Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Meningitis vaccines near commercialization in Canada

Nov. 7, 2001

Novartis seeks European marketing authorization for Myfortic

Nov. 7, 2001

Tanox designs anticomplement monoclonal antibodies for autoimmune and inflammatory diseases

Nov. 6, 2001

Ribi-529 adjuvant added to Corixa/Wyeth Lederle Vaccines license agreement

Nov. 6, 2001

TolerRx to advance lead product with completion of financing

Nov. 2, 2001

Two vaccines for HPV prove effective in clinical trials

Oct. 31, 2001

Sankyo presents new inhibitors of macrophage activity

Oct. 24, 2001

Antex concludes Phase I of SBIR grant from U.S. Army

Oct. 23, 2001

Oxamide-based inhibitors of IMPDH under study at Roche

Oct. 11, 2001

Xenova terminates TA-HSV development, DISC-PRO studies continue

Oct. 11, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...